RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune system vs. leukemia: major trial tests new weapon for kids
Disease control OngoingThis large, late-stage trial is comparing a new immunotherapy drug called blinatumomab against standard chemotherapy for children and young adults whose B-cell acute lymphoblastic leukemia (B-ALL) has returned after initial treatment. The study aims to see if using the body's own…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Targeted missile drug aims to wipe out last traces of leukemia
Disease control OngoingThis study is testing a targeted drug called inotuzumab ozogamicin for adults with B-cell acute lymphoblastic leukemia (ALL) who are in remission but still have tiny amounts of cancer cells detectable by sensitive tests. The drug is designed to seek out and destroy these remainin…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug duo aims to knock out stubborn leukemia
Disease control OngoingThis study is testing a combination of two drugs, venetoclax and vincristine, for adults with a fast-growing blood cancer called acute lymphoblastic leukemia (ALL) that has come back or hasn't responded to previous treatments. The goal is to see if using these drugs together is s…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for tough leukemia: gentler chemo combo trial
Disease control OngoingThis study is testing a new treatment approach for adults with acute lymphoblastic leukemia (ALL) that has returned or not responded to prior therapy. It combines a targeted drug called venetoclax with a lower-intensity chemotherapy regimen. The goal is to see if this combination…
Matched conditions: RECURRENT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC